Piramal Life Sciences posts Q4 loss at Rs37.36 cr

Piramal Life Sciences posts Q4 loss at Rs37.36 cr
PTI
Comment E-mail Print Share
First Published: Sat, Apr 25 2009. 02 11 PM IST
Updated: Sat, Apr 25 2009. 02 11 PM IST
Mumbai: Piramal Group’s spun-off research and development arm, Piramal Life Sciences on Saturday reported a net loss of Rs37.36 crore for the fourth quarter ended 31 March 2009.
The drug R&D firm had a net profit of Rs52 lakh in the March quarter of FY09, Piramal Life Sciences said in a filing to the Bombay Stock Exchange (BSE).
The company listed itself on the bourses in May last year. “Since this is the first year of results of the company published subsequent to listing of shares and as the company has not any operations during the corresponding quarter in the previous year, the figures for previous quarter are not furnished,” the filing added.
Comment E-mail Print Share
First Published: Sat, Apr 25 2009. 02 11 PM IST